B. Ostenstad et al., A BOY WITH X-LINKED HYPER-IGM SYNDROME AND NATURAL-KILLER-CELL DEFICIENCY, Clinical and experimental immunology, 107(2), 1997, pp. 230-234
We present a boy with hyper-IgM syndrome with a previously not reporte
d mutation in the CD40 ligand gene. He also had a concomitant natural
killer (NK) cell deficiency. He had no CD56(+) or CD16(+) cells and no
NK activity as determined in 4h chromium release cytotoxicity assay.
After 5 days in culture with IL-2-containing medium, however, his peri
pheral blood mononuclear cells lysed both NK-sensitive and NK-resistan
t targets, showing that he had lymphokine-activated killer cell precur
sors in the circulation. Due to the associated neutropenia, he was tre
ated with granulocyte colony-stimulating factor (G-CSF) and responded
well. In the same period we observed a transient increase in the numbe
r of NK cells, Isolated NK cell deficiencies an extremely rare. We sug
gest that the defect in our patient is part of the hyper-IgM syndrome,
probably representing the phenotype of the new mutation described. Th
us, it is possible that both the neutropenia and the NK cell deficienc
y are due to lack of growth-promoting signals normally delivered by th
e CD40 ligand.